These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 30166694)

  • 21. UTX and MLL4 coordinately regulate transcriptional programs for cell proliferation and invasiveness in breast cancer cells.
    Kim JH; Sharma A; Dhar SS; Lee SH; Gu B; Chan CH; Lin HK; Lee MG
    Cancer Res; 2014 Mar; 74(6):1705-17. PubMed ID: 24491801
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dual Inhibition of EZH2 and EZH1 Sensitizes PRC2-Dependent Tumors to Proteasome Inhibition.
    Rizq O; Mimura N; Oshima M; Saraya A; Koide S; Kato Y; Aoyama K; Nakajima-Takagi Y; Wang C; Chiba T; Ma A; Jin J; Iseki T; Nakaseko C; Iwama A
    Clin Cancer Res; 2017 Aug; 23(16):4817-4830. PubMed ID: 28490465
    [No Abstract]   [Full Text] [Related]  

  • 23. JMJD3 as an epigenetic regulator in development and disease.
    Burchfield JS; Li Q; Wang HY; Wang RF
    Int J Biochem Cell Biol; 2015 Oct; 67():148-57. PubMed ID: 26193001
    [TBL] [Abstract][Full Text] [Related]  

  • 24. UTX-1 regulates Tat-induced HIV-1 transactivation via changing the methylated status of histone H3.
    Zhang HS; Du GY; Liu Y; Zhang ZG; Zhou Z; Li H; Dai KQ; Yu XY; Gou XM
    Int J Biochem Cell Biol; 2016 Nov; 80():51-56. PubMed ID: 27671333
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression and significance of histone H3K27 demethylases in renal cell carcinoma.
    Shen Y; Guo X; Wang Y; Qiu W; Chang Y; Zhang A; Duan X
    BMC Cancer; 2012 Oct; 12():470. PubMed ID: 23057811
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of the Histone H3K27 Demethylase UTX Enhances Tumor Cell Radiosensitivity.
    Rath BH; Waung I; Camphausen K; Tofilon PJ
    Mol Cancer Ther; 2018 May; 17(5):1070-1078. PubMed ID: 29483212
    [TBL] [Abstract][Full Text] [Related]  

  • 27. UTX inhibition as selective epigenetic therapy against TAL1-driven T-cell acute lymphoblastic leukemia.
    Benyoucef A; Palii CG; Wang C; Porter CJ; Chu A; Dai F; Tremblay V; Rakopoulos P; Singh K; Huang S; Pflumio F; Hébert J; Couture JF; Perkins TJ; Ge K; Dilworth FJ; Brand M
    Genes Dev; 2016 Mar; 30(5):508-21. PubMed ID: 26944678
    [TBL] [Abstract][Full Text] [Related]  

  • 28. DOT1L inhibition blocks multiple myeloma cell proliferation by suppressing IRF4-MYC signaling.
    Ishiguro K; Kitajima H; Niinuma T; Ishida T; Maruyama R; Ikeda H; Hayashi T; Sasaki H; Wakasugi H; Nishiyama K; Shindo T; Yamamoto E; Kai M; Sasaki Y; Tokino T; Nakase H; Suzuki H
    Haematologica; 2019 Jan; 104(1):155-165. PubMed ID: 30171029
    [TBL] [Abstract][Full Text] [Related]  

  • 29. H3K27me3 Demethylase UTX Restrains Plasma Cell Formation.
    Kania AK; Price MJ; George-Alexander LE; Patterson DG; Hicks SL; Scharer CD; Boss JM
    J Immunol; 2022 Apr; 208(8):1873-1885. PubMed ID: 35346967
    [TBL] [Abstract][Full Text] [Related]  

  • 30. KDM6A regulates immune response genes in multiple myeloma.
    Dupéré-Richer D; Riva A; Barwick BG; Maji S; Casellas Román H; Li J; De U; Sobh A; Quickstad G; Piper C; Kulis M; Ezponda T; Martín-Subero JI; Tonon G; Zhang W; Mitsiades CS; Boise LH; Bennett RL; Licht JD
    Blood; 2024 Oct; 144(14):1508-1520. PubMed ID: 39046770
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of Histone H3K27 Demethylases Inactivates Brachyury (TBXT) and Promotes Chordoma Cell Death.
    Cottone L; Cribbs AP; Khandelwal G; Wells G; Ligammari L; Philpott M; Tumber A; Lombard P; Hookway ES; Szommer T; Johansson C; Brennan PE; Pillay N; Jenner RG; Oppermann U; Flanagan AM
    Cancer Res; 2020 Oct; 80(20):4540-4551. PubMed ID: 32855205
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vivo CRISPR screening unveils histone demethylase UTX as an important epigenetic regulator in lung tumorigenesis.
    Wu Q; Tian Y; Zhang J; Tong X; Huang H; Li S; Zhao H; Tang Y; Yuan C; Wang K; Fang Z; Gao L; Hu X; Li F; Qin Z; Yao S; Chen T; Chen H; Zhang G; Liu W; Sun Y; Chen L; Wong KK; Ge K; Chen L; Ji H
    Proc Natl Acad Sci U S A; 2018 Apr; 115(17):E3978-E3986. PubMed ID: 29632194
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Novel epigenetic therapies for multiple myeloma].
    Mimura N
    Rinsho Ketsueki; 2021; 62(4):314-320. PubMed ID: 33967157
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of UTX in retinoic acid receptor-mediated gene regulation in leukemia.
    Rocha-Viegas L; Villa R; Gutierrez A; Iriondo O; Shiekhattar R; Di Croce L
    Mol Cell Biol; 2014 Oct; 34(19):3765-75. PubMed ID: 25071154
    [TBL] [Abstract][Full Text] [Related]  

  • 35. C-terminal binding protein 2 is a novel tumor suppressor targeting the MYC-IRF4 axis in multiple myeloma.
    Cheung CHY; Cheng CK; Leung KT; Zhang C; Ho CY; Luo X; Kam AYF; Xia T; Wan TSK; Pitts HA; Chan NPH; Cheung JS; Wong RSM; Zhang XB; Ng MHL
    Blood Adv; 2024 May; 8(9):2217-2234. PubMed ID: 38457926
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epigenetic regulation of E-cadherin expression by the histone demethylase UTX in colon cancer cells.
    Zha L; Cao Q; Cui X; Li F; Liang H; Xue B; Shi H
    Med Oncol; 2016 Mar; 33(3):21. PubMed ID: 26819089
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nicotine induces alteration of H3K27 demethylase UTX in kidney cancer cell.
    Guo X; Li X; Wang Y; Tian Z; Duan X; Cai Z
    Hum Exp Toxicol; 2014 Mar; 33(3):264-9. PubMed ID: 23925944
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Selective inhibition of EZH2 by ZLD1039 blocks H3K27 methylation and leads to potent anti-tumor activity in breast cancer.
    Song X; Gao T; Wang N; Feng Q; You X; Ye T; Lei Q; Zhu Y; Xiong M; Xia Y; Yang F; Shi Y; Wei Y; Zhang L; Yu L
    Sci Rep; 2016 Feb; 6():20864. PubMed ID: 26868841
    [TBL] [Abstract][Full Text] [Related]  

  • 39. UTX Mutations in Human Cancer.
    Wang L; Shilatifard A
    Cancer Cell; 2019 Feb; 35(2):168-176. PubMed ID: 30753822
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Coordinated demethylation of H3K9 and H3K27 is required for rapid inflammatory responses of endothelial cells.
    Higashijima Y; Matsui Y; Shimamura T; Nakaki R; Nagai N; Tsutsumi S; Abe Y; Link VM; Osaka M; Yoshida M; Watanabe R; Tanaka T; Taguchi A; Miura M; Ruan X; Li G; Inoue T; Nangaku M; Kimura H; Furukawa T; Aburatani H; Wada Y; Ruan Y; Glass CK; Kanki Y
    EMBO J; 2020 Apr; 39(7):e103949. PubMed ID: 32125007
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.